Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
2023 | Dottikon ES Posts Lower Fiscal H1 Net Income; Sales Up | MT |
2023 | Dottikon ES Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Business Summary
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemicals, Intermediates, and Exclusive Active Pharmaceutical Ingredients
100.0
%
| 252 | 100.0 % | 319 | 100.0 % | +26.80% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 252 | 100.0 % | 319 | 100.0 % | +26.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 53 | 02-12-31 |
Marlene Born
DFI | Director of Finance/CFO | 49 | 04-12-31 |
Urs Brändli
CTO | Chief Tech/Sci/R&D Officer | 64 | 89-12-31 |
Karin Krause
HRO | Human Resources Officer | 56 | 14-12-31 |
Corporate Officer/Principal | 57 | 08-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 53 | 02-12-31 |
Director/Board Member | 67 | 11-06-30 | |
Bernhard Urwyler
BRD | Director/Board Member | 66 | 20-07-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,999,084 | 3,901,112 ( 27.87 %) | 224,880 ( 1.606 %) | 27.87 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DOTTIKON ES HOLDING AG 1.38% | 193,641 | 1.38% | 50,672,016 $ |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- DESN Stock
- 0QJU Stock
- Company Dottikon ES Holding AG